메뉴 건너뛰기




Volumn 31, Issue 7, 2007, Pages 1440-1443

The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features

Author keywords

ERP; Event related potentials; Major depression; Psychotic; Sertraline; Ziprasidone

Indexed keywords

LORAZEPAM; PROLACTIN; SERTRALINE; ZIPRASIDONE;

EID: 34548120216     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.06.021     Document Type: Article
Times cited : (7)

References (30)
  • 1
    • 13744256171 scopus 로고    scopus 로고
    • Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial
    • Addington D.R., Pantelis C., Dineen M., Benattia I., and Romano S.J. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial. J Clin Psychiatry 65 (2004) 1624-1633
    • (2004) J Clin Psychiatry , vol.65 , pp. 1624-1633
    • Addington, D.R.1    Pantelis, C.2    Dineen, M.3    Benattia, I.4    Romano, S.J.5
  • 2
    • 0031680745 scopus 로고    scopus 로고
    • Visual cognitive dysfunction in depression: an event-related potential study
    • Bange F., and Bathien N. Visual cognitive dysfunction in depression: an event-related potential study. Electroencephalogr Clin Neurophysiol 108 (1998) 472-481
    • (1998) Electroencephalogr Clin Neurophysiol , vol.108 , pp. 472-481
    • Bange, F.1    Bathien, N.2
  • 4
    • 33846581048 scopus 로고    scopus 로고
    • Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment resistant depression
    • Baune B.T., Caliskan S., and Todder D. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment resistant depression. Hum Psychopharmacol 22 (2006) 1-9
    • (2006) Hum Psychopharmacol , vol.22 , pp. 1-9
    • Baune, B.T.1    Caliskan, S.2    Todder, D.3
  • 6
    • 0025913261 scopus 로고
    • Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency
    • Bruder G.E., Towey J.P., Stewart J.W., Friedman D., Tenke C., and Quitkin F.M. Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency. Biol Psychiatry 30 (1991) 233-246
    • (1991) Biol Psychiatry , vol.30 , pp. 233-246
    • Bruder, G.E.1    Towey, J.P.2    Stewart, J.W.3    Friedman, D.4    Tenke, C.5    Quitkin, F.M.6
  • 7
    • 15744400568 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression
    • Calabrese J.R., Keck Jr. P.E., Macfadden W., Minkwitz M., Ketter T.A., Weisler R.H., et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162 (2005) 1351-1360
    • (2005) Am J Psychiatry , vol.162 , pp. 1351-1360
    • Calabrese, J.R.1    Keck Jr., P.E.2    Macfadden, W.3    Minkwitz, M.4    Ketter, T.A.5    Weisler, R.H.6
  • 9
    • 0035903767 scopus 로고    scopus 로고
    • The impact of transcranial magnetic stimulation on cognitive processing: an event-related potential study
    • Evers S., Böckermann I., and Nyhuis P.W. The impact of transcranial magnetic stimulation on cognitive processing: an event-related potential study. NeuroReport 12 (2001) 2915-2918
    • (2001) NeuroReport , vol.12 , pp. 2915-2918
    • Evers, S.1    Böckermann, I.2    Nyhuis, P.W.3
  • 10
    • 0015828197 scopus 로고
    • Inter-and intra-rater reliability of the Brief Psychiatric Rating Scale
    • Flemenbaum A., and Zimmermann R.L. Inter-and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol Rep 32 (1973) 783-792
    • (1973) Psychol Rep , vol.32 , pp. 783-792
    • Flemenbaum, A.1    Zimmermann, R.L.2
  • 13
    • 0014186152 scopus 로고
    • Development of a rating scale for primary depressive illness
    • Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
    • (1967) Br J Soc Clin Psychol , vol.6 , pp. 278-296
    • Hamilton, M.1
  • 14
    • 4644371360 scopus 로고    scopus 로고
    • The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
    • Hetzel G., Moeller O., Erfurth A., Michael N., Rothermundt M., Arolt V., et al. The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients. Pharmacopsychiatry 37 (2004) 200-205
    • (2004) Pharmacopsychiatry , vol.37 , pp. 200-205
    • Hetzel, G.1    Moeller, O.2    Erfurth, A.3    Michael, N.4    Rothermundt, M.5    Arolt, V.6
  • 15
    • 15044346892 scopus 로고    scopus 로고
    • The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment
    • Hetzel G., Moeller O., Evers S., Erfurth A., Ponath G., Arolt V., et al. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology (Berl) 178 (2005) 161-166
    • (2005) Psychopharmacology (Berl) , vol.178 , pp. 161-166
    • Hetzel, G.1    Moeller, O.2    Evers, S.3    Erfurth, A.4    Ponath, G.5    Arolt, V.6
  • 16
    • 0032808996 scopus 로고    scopus 로고
    • A study of P300-event related evoked potential in the patients of major depression
    • Himani A., Tandon O.P., and Bhatia M.S. A study of P300-event related evoked potential in the patients of major depression. Indian J Physiol Pharmacol 43 (1999) 367-372
    • (1999) Indian J Physiol Pharmacol , vol.43 , pp. 367-372
    • Himani, A.1    Tandon, O.P.2    Bhatia, M.S.3
  • 17
    • 0037303744 scopus 로고    scopus 로고
    • P300 changes in major depressive disorders with and without psychotic features
    • Karaaslan F., Gonul A.S., Oguz A., Erdinc E., and Esel E. P300 changes in major depressive disorders with and without psychotic features. J Affect Disord 73 (2003) 283-287
    • (2003) J Affect Disord , vol.73 , pp. 283-287
    • Karaaslan, F.1    Gonul, A.S.2    Oguz, A.3    Erdinc, E.4    Esel, E.5
  • 18
    • 33646681652 scopus 로고    scopus 로고
    • A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms
    • Kinon B.J., Lipkovich I., Edwards S.B., Adams D.H., Ascher-Svanum H., and Siris S.G. A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms. J Clin Psychopharmacol 26 (2006) 157-162
    • (2006) J Clin Psychopharmacol , vol.26 , pp. 157-162
    • Kinon, B.J.1    Lipkovich, I.2    Edwards, S.B.3    Adams, D.H.4    Ascher-Svanum, H.5    Siris, S.G.6
  • 21
    • 0018425438 scopus 로고
    • A new depression scale designed to be sensitive to change
    • Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
    • (1979) Br J Psychiatry , vol.134 , pp. 382-389
    • Montgomery, S.A.1    Asberg, M.2
  • 22
    • 1842855918 scopus 로고    scopus 로고
    • Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder
    • Papakostas G.I., Petersen T.J., Nierenberg A.A., Murakami J.L., Alpert J.E., Rosenbaum J.F., et al. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. J Clin Psychiatry 65 (2004) 217-221
    • (2004) J Clin Psychiatry , vol.65 , pp. 217-221
    • Papakostas, G.I.1    Petersen, T.J.2    Nierenberg, A.A.3    Murakami, J.L.4    Alpert, J.E.5    Rosenbaum, J.F.6
  • 23
    • 0030603836 scopus 로고    scopus 로고
    • Rapid rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression
    • Pascual-Leone A., Rubio B., Pallardo F., and Catala M.D. Rapid rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 348 (1996) 233-237
    • (1996) Lancet , vol.348 , pp. 233-237
    • Pascual-Leone, A.1    Rubio, B.2    Pallardo, F.3    Catala, M.D.4
  • 24
    • 0026485290 scopus 로고
    • Diazepam effects on the P3 event-related potential
    • Ray P.G., Meador K.J., and Loring D.W. Diazepam effects on the P3 event-related potential. J Clin Psychopharmacol 12 (1992) 415-419
    • (1992) J Clin Psychopharmacol , vol.12 , pp. 415-419
    • Ray, P.G.1    Meador, K.J.2    Loring, D.W.3
  • 25
    • 4744338410 scopus 로고    scopus 로고
    • Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder
    • Simpson G.M., Glick I.D., Weiden P.J., Romano S.J., and Siu C.O. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Am J Psychiatry 161 (2004) 1837-1847
    • (2004) Am J Psychiatry , vol.161 , pp. 1837-1847
    • Simpson, G.M.1    Glick, I.D.2    Weiden, P.J.3    Romano, S.J.4    Siu, C.O.5
  • 26
    • 33751116553 scopus 로고    scopus 로고
    • Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)
    • Thase M.E., Macfadden W., Weisler R.H., Chang W., Paulsson B., Khan A., et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 26 (2006) 600-609
    • (2006) J Clin Psychopharmacol , vol.26 , pp. 600-609
    • Thase, M.E.1    Macfadden, W.2    Weisler, R.H.3    Chang, W.4    Paulsson, B.5    Khan, A.6
  • 27
    • 33751103685 scopus 로고    scopus 로고
    • Locomotor activity and quality of sleep in Quetiapine treated patients with depression
    • Todder D., Caliskan S., and Baune B.T. Locomotor activity and quality of sleep in Quetiapine treated patients with depression. J Clin Psychopharmacol 26 (2006) 638-642
    • (2006) J Clin Psychopharmacol , vol.26 , pp. 638-642
    • Todder, D.1    Caliskan, S.2    Baune, B.T.3
  • 28
    • 0031782492 scopus 로고    scopus 로고
    • Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude
    • Vandoolaeghe E., van Hunsel F., Nuyten D., and Maes M. Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude. J Affect Disord 48 (1998) 105-113
    • (1998) J Affect Disord , vol.48 , pp. 105-113
    • Vandoolaeghe, E.1    van Hunsel, F.2    Nuyten, D.3    Maes, M.4
  • 29
    • 0017306128 scopus 로고    scopus 로고
    • World Medical Association: Declaration of Helsinki (1976). Recommendations guiding medical doctors in biomedical research involving human subjects. Med J Aust; 1: 206-7
  • 30
    • 0003031424 scopus 로고    scopus 로고
    • Changes in auditory P300 in patients with major depression and silent cerebral infarction
    • Yanai I., Fujikawa T., Osada M., Yamawaki S., and Touhouda Y. Changes in auditory P300 in patients with major depression and silent cerebral infarction. J Affect Disord 46 (1997) 263-271
    • (1997) J Affect Disord , vol.46 , pp. 263-271
    • Yanai, I.1    Fujikawa, T.2    Osada, M.3    Yamawaki, S.4    Touhouda, Y.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.